New Delhi, India

Gannavaran Sreenivas

This inventor holds 1 USPTO granted patent. Top assignee: Indian Council of Medical Research. Active years: 2005.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gannavaran Sreenivas: Innovator in Leishmaniasis Detection

Introduction: Gannavaran Sreenivas is a notable inventor based in New Delhi, India. He has made significant contributions to the field of medical research, particularly in the diagnosis of leishmaniasis. His work focuses on developing innovative solutions to improve the detection of this disease, which affects many individuals worldwide.

Latest Patents: Gannavaran Sreenivas holds a patent for a "Species-specific PCR assay for detection of Leishmania donovani in clinical samples of kala-azar and post kala-azar dermal leishmaniasis." This invention relates to a polymerase chain reaction (PCR) assay that utilizes specific oligonucleotide primers for the identification of parasites in clinical samples. His patent represents a crucial advancement in the diagnosis of leishmaniasis, providing a reliable method for detecting the disease in affected individuals.

Career Highlights: Gannavaran Sreenivas is affiliated with the Indian Council of Medical Research, where he conducts research aimed at improving public health outcomes. His dedication to medical research has led to advancements in diagnostic techniques, particularly in the field of infectious diseases.

Collaborations: Gannavaran has worked alongside esteemed colleagues such as Poonam Salotra and Gregory P Pogue. Their collaborative efforts have contributed to the development of innovative diagnostic methods and have furthered research in the field of leishmaniasis.

Conclusion: Gannavaran Sreenivas is a prominent inventor whose work in the detection of leishmaniasis has made a significant impact on medical research. His contributions continue to enhance the understanding and diagnosis of this disease, ultimately benefiting public health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…